Insiders · Profile

Ryweck Daniel E.

Chief Financial Officer at Silo Pharma. Filing since 26 May 2023. CIK 0001652799

Company

Date

Role

Action

Amount

Of holding

26 May 2023

Chief Financial Officer

Bought

1,000

$2.13K

25.0%

1 decision on file.